4CPS-072 Are we properly dosing antibiotics in enterococcus faecium bacteraemia?

BACKGROUND: The incidence of Enterococcus faecium infections has increased over the past years and is currently the third major microorganism implicated in nosocomial bacteraemia. Nevertheless, the best treatment available is yet to be established, especially in vancomycin-susceptible E. faecium. In...

詳細記述

保存先:
書誌詳細
出版年:Eur J Hosp Pharm
主要な著者: Echeverria-Esnal, D, Sorli, L, Barcelo, J, Fernandez, X, Martin-Ontiyuelo, C, Pardos, S Luque, Marin-Casino, M, Salas, E, Horcajada, JP, Grau, S
フォーマット: Artigo
言語:Inglês
出版事項: BMJ Group 2018
主題:
Section 4: Clinical pharmacy services
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535612/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.163
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料